B.Sc. [Physics (honours with distinction)], University of Victoria
M.Sc. [Physics], University of British Columbia
Ph.D. [Physics], University of British Columbia
Assistant Professor, Department of Medicine, Division of Neurology, University of British Columbia
Associate Member, Department of Radiology, University of British Columbia
Associate Member, Department of Physics and Astronomy, University of British Columbia
Investigator, Djavad Mowafaghian Centre for Brain Health, University of British Columbia
Co-Director, MS/MRI Research Group,University of British Columbia
Research InterestsAxons; Central Nervous System; Disease; inflammation; Injury; MRI; Myelin; Neurodegeneration
Dr. Shannon Kolind earned her PhD in Physics at UBC developing myelin water imaging and its application to the study of multiple sclerosis (MS). She then completed a postdoctoral fellowship at the Oxford Centre for Functional MRI of the Brain (FMRIB) at the University of Oxford as well as the Institute of Psychiatry, King’s College London. While in the UK, she specialised in developing new methods to image myelin using MRI, and making them more practical for use in research. She then returned to UBC, this time in the Division of Neurology, to become an Assistant Professor. Shannon’s lab is focused on developing a toolbox of tissue-specific imaging techniques. Her multi-disciplinary team employs these multi-modal tools to achieving greater sensitivity and specificity in clinical research; particularly for clinical trials of new therapies.
Techniques employed in the labs:
- Quantitative MRI
- Conventional MRI
- Cognitive testing
- Data analysis technique development
Affiliation with organizations and societies:
- International Society for Magnetic Resonance in Medicine (ISMRM)
- American Academy of Neurology (AAN)
- North American Imaging in Multiple Sclerosis Consortium (NAIMS)
Some of Dr. Kolind’s recent major awards and accomplishments include:
Principal Investigator, Operating Grant (Multiple Sclerosis Society of Canada, 2017-2020)
Current Lab Members:
|Masters Students||Ph.D. Students||Research Staff|
|Lisa Eunyoung Lee||Shawna Abel||
|Adam Dvorak||Anna Combes (King’s College London)||Heather Yong|
|Emil Ljungberg (King’s College London)||Irene Vavasour|
|2017||Lisa Eunyoung Lee||Vancouver Korean-Canadian Scholarship|
|2017||Emilie Russell||Travel Award (European Committee for Treatment & Research in Multiple Sclerosis)|
|2017||Emil Ljungberg||Poster Finalist (International Society for Magnetic Resonance in Medicine)|
|2017||Emil Ljungberg||Travel Award (International Society for Magnetic Resonance in Medicine)|
|2017||Lisa Eunyoung Lee||Travel Award (International Society for Magnetic Resonance in Medicine)|
|2017||Dayna Ortner||Travel Award (International Society for Magnetic Resonance in Medicine)|
|2017||Anna Combes||Travel Award (International Society for Magnetic Resonance in Medicine)|
|2017||Anna Combes||Travel Award (Guarantors of Brain)|
|2017||Lisa Eunyoung Lee||Travel Award (Workshop on Quantitative MRI in White Matter Disorders)|
|2016||Anna Combes||Poster Award First Place (International Society for Magnetic Resonance in Medicine)|
- Johnson, P et al.. 2022. Myelin heterogeneity for assessing normal appearing white matter myelin damage in multiple sclerosis.. J Neuroimaging. doi: 10.1111/jon.13069.
- Vavasour, IM et al.. 2022. A pilot study comparing myelin measurements from myelin water imaging and 11C-PIB PET in multiple sclerosis.. Mult Scler Relat Disord. doi: 10.1016/j.msard.2022.104238.
- Kolind, S et al.. 2022. Myelin water imaging in relapsing multiple sclerosis treated with ocrelizumab and interferon beta-1a.. Neuroimage Clin. doi: 10.1016/j.nicl.2022.103109.
- Balaji, S, Johnson, P, Dvorak, AV, Kolind, SH. 2022. Update on myelin imaging in neurological syndromes.. Curr Opin Neurol. doi: 10.1097/WCO.0000000000001078.
- Arnold, DL et al.. 2022. Ocrelizumab reduces thalamic volume loss in patients with RMS and PPMS.. Mult Scler. doi: 10.1177/13524585221097561.